Home
About Pharmos
Development
Plan
Dextofisopam for IBS
Dextofisopam Publication: Phase 2a Results
Tianeptine for IBS
CB2-Selective Program: Cannabinor
CB2-Selective Program: Second-Generation Compounds
Investors
News Room
Business Development
Careers
Contact Us
Home
|
About Pharmos
|
Development Plan
|
Investors
|
News Room
|
Contact Us
©Copyright 2001-2003, Pharmos Corporation. All Rights Reserved.
